BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12506864)

  • 1. Sexual dysfunction and HAART--is there a connection?
    Dunable D
    Surviv News (Atlanta Ga); 2002 Nov; ():9. PubMed ID: 12506864
    [No Abstract]   [Full Text] [Related]  

  • 2. Sexual dysfunction and HAART.
    TreatmentUpdate; 2001 Aug; 13(4):5-7. PubMed ID: 11590980
    [No Abstract]   [Full Text] [Related]  

  • 3. Sexual dysfunction in the highly active antiretroviral therapy era.
    Collazos J
    AIDS Rev; 2007; 9(4):237-45. PubMed ID: 18219367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV treatment adherence and sexual functioning.
    Miguez-Burbano MJ; Espinoza L; Lewis JE
    AIDS Behav; 2008 Jan; 12(1):78-85. PubMed ID: 17295075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Side effects. Male sexual dysfunction and HAART--the confusion continues.
    TreatmentUpdate; 2002 Jul; 14(5):4. PubMed ID: 12141281
    [No Abstract]   [Full Text] [Related]  

  • 6. Unexpected improvement of sexual dysfunction during atazanavir therapy.
    Colebunders R; Moerman F; Nöestlinger C
    AIDS; 2006 May; 20(8):1209-10. PubMed ID: 16691078
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiretroviral therapy is associated with sexual dysfunction and with increased serum oestradiol levels in men.
    Lamba H; Goldmeier D; Mackie NE; Scullard G
    Int J STD AIDS; 2004 Apr; 15(4):234-7. PubMed ID: 15075015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretrovirals and cardiovascular disease: is HAART bad for your heart?
    Fichtenbaum CJ
    AIDS Clin Care; 2003 Aug; 15(8):69-73, 76. PubMed ID: 12945527
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
    Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HAART, side effects, and viral transmission.
    Laurence J
    AIDS Read; 2004 May; 14(5):210-1. PubMed ID: 15198078
    [No Abstract]   [Full Text] [Related]  

  • 11. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with sexual dysfunction in men with HIV infection.
    Richardson D; Lamba H; Goldmeier D; Nalabanda A; Harris JR
    Int J STD AIDS; 2006 Nov; 17(11):764-7. PubMed ID: 17062182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HAART at 10: an interview with Cal Cohen.
    Cohen C
    Res Initiat Treat Action; 2005; 11(1):49-51. PubMed ID: 16208821
    [No Abstract]   [Full Text] [Related]  

  • 14. Hospitalizations of pregnant HIV-infected women in the United States in the era of highly active antiretroviral therapy (HAART).
    Bansil P; Jamieson DJ; Posner SF; Kourtis AP
    J Womens Health (Larchmt); 2007 Mar; 16(2):159-62. PubMed ID: 17388731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic hepatitis C in HIV-infected patients receiving highly active antiretroviral therapy (HAART)].
    Halota W; Pawłowska M
    Przegl Epidemiol; 2002; 56 Suppl 5():41-5. PubMed ID: 15553071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour.
    Smit C; Lindenburg K; Geskus RB; Brinkman K; Coutinho RA; Prins M
    Addiction; 2006 Mar; 101(3):433-40. PubMed ID: 16499516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients.
    Kong HH; Myers SA
    Dermatol Ther; 2005; 18(1):58-66. PubMed ID: 15842613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peyronie's disease in men with HIV responding to highly active antiretroviral therapy.
    Rogers GD; French MA
    HIV Med; 2004 May; 5(3):185-6. PubMed ID: 15139986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act.
    Burgoyne RW; Tan DH
    J Antimicrob Chemother; 2008 Mar; 61(3):469-73. PubMed ID: 18174196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary gland function in HIV-infected patients treated with highly active antiretroviral therapy (HAART).
    Lin AL; Johnson DA; Sims CA; Stephan KT; Yeh CK
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep; 102(3):318-24. PubMed ID: 16920540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.